
A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …

A study emerging from St George’s University of London found that children who slept an hour less than the recommended …

A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …

Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …

Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …

A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …

Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option …

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …

In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection …

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …

In its second quarter financial reports, Valeant strove to strike a positive note. It revealed that it had paid down …

Only last week it was revealed that the UK would administer all babes with the hepatitis B vaccine to reduce …

In research that will have many women nodding their brain-boxes, a study has found that analysis of thousands of brains …